SCHEMBL9185474

SCHEMBL9185474

CNC(COc1cccc2ncccc12)CN1CCN(C(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 4/20 0.56
▸ KMT2A Q03164 6/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ TSHR P16473 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ ALOX15 P16050 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ MAPT P10636 3/20 0.45
▸ ADRB2 P07550 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ MEN1 O00255 5/20 0.43
▸ P2RX7 Q99572 1/20 0.42
▸ HTR1A P08908 1/20 0.41
▸ HTR1D P28221 1/20 0.41
▸ HTR1B P28222 1/20 0.41
▸ KCNH2 Q12809 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9183346 0.86 ABCB1 (0.74) ABCB1KMT2AALDH1A1TSHRLMNA
SCHEMBL9189012 0.85 ABCB1 (0.57) ABCB1KMT2AALDH1A1TSHRLMNA
SCHEMBL9186320 0.85 ABCB1 (0.59) ABCB1KMT2AALDH1A1TSHRLMNA
SCHEMBL9183180 0.82 ABCB1 (0.69) ABCB1KMT2AALDH1A1TSHRLMNA
SCHEMBL9184024 0.82 ABCB1 (0.69) ABCB1KMT2AALDH1A1TSHRLMNA
SCHEMBL9184822 0.81 ABCB1 (0.60) ABCB1KMT2AALDH1A1TSHRLMNA
SCHEMBL9187504 0.81 ABCB1 (0.67) ABCB1KMT2AALDH1A1TSHRLMNA
SCHEMBL9186185 0.81 ABCB1 (0.67) ABCB1KMT2AALDH1A1TSHRLMNA
SCHEMBL9180280 0.80 MEN1 (0.60) ABCB1KMT2AALDH1A1LMNAGAA
SCHEMBL9183197 0.80 ABCB1 (0.68) ABCB1KMT2AALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 — — US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 — — EP disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 — — US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 — — US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 — — EP disclosed
Send feedback